KHA‐CARI guideline: Dialysis adequacy (haemodialysis): Dialysis membranes
作者： Peter G Kerr , Nigel D Toussaint
DOI: 10.1111/NEP.12096
关键词:
摘要: GUIDELINE RECOMMENDATIONS • We recommend that either synthetic or cellulosic membranes be used for symptomatic intra-dialytic hypotension as offer no benefit over (1C). high-flux to remove molecules such beta-2 microglobulin because they have been shown achieve lower serum levels (1A). suggest there are possible survival benefits from some groups those on dialysis more than 3.7 years, with a albumin below 40 g/L and diabetics
cari.org.au参考文章(25)
Mrowka C, Schiffl H, Comparative evaluation of beta-2-microglobulin removal by different hemodialysis membranes A six-year follow-up Nephron. ,vol. 63, pp. 368- 369 ,(1993) , 10.1159/000187232
Alison M MacLeod, Marion K Campbell, June D Cody, Conal Daly, Adrian Grant, Izhar Khan, Kannaiyan S Rabindranath, Luke Vale, Sheila A Wallace, None, Cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end‐stage renal disease Cochrane Database of Systematic Reviews. ,(2005) , 10.1002/14651858.CD003234.PUB2
Claudius Küchle, Harald Fricke, Eckhart Held, Helmut Schiffl, High-flux hemodialysis postpones clinical manifestation of dialysis-related amyloidosis. American Journal of Nephrology. ,vol. 16, pp. 484- 488 ,(1996) , 10.1159/000169048
Yutaka Koda, Shin-Ichi Nishi, Shigeru Miyazaki, Susumu Haginoshita, Tai Sakurabayashi, Masashi Suzuki, Shinji Sakai, Yasuko Yuasa, Yoshihei Hirasawa, Tsugio Nishi, Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients Kidney International. ,vol. 52, pp. 1096- 1101 ,(1997) , 10.1038/KI.1997.434
Philippe Chauveau, Hiep Nguyen, Christian Combe, Geneviève Chêne, Raymond Azar, Noël Cano, Bernard Canaud, Denis Fouque, Maurice Laville, Xavier Leverve, Hubert Roth, Michel Aparicio, French Study Group for Nutrition in Dialysis, Dialyzer membrane permeability and survival in hemodialysis patients American Journal of Kidney Diseases. ,vol. 45, pp. 565- 571 ,(2005) , 10.1053/J.AJKD.2004.11.014
Friedrich K. Port, Robert A. Wolfe, Tempie E. Hulbert-Shearon, John T. Daugirdas, Lawrence Y.C. Agodoa, Camille Jones, Sean M. Orzol, Philip J. Held, Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the usrds dialysis morbidity and mortality study. American Journal of Kidney Diseases. ,vol. 37, pp. 276- 286 ,(2001) , 10.1053/AJKD.2001.21290
A. Klemm, C. Franke, M. Busch, A. Müller, S. Franke, D. Lang, J. Passlick-Deetjen, G. Stein, Influence of hemodialysis membrane permeability on serum levels of advanced glycation end products (AGEs) and homocysteine metabolites. Clinical Nephrology. ,vol. 61, pp. 191- 197 ,(2004) , 10.5414/CNP61191
Francesco Locatelli, Adelheid Gauly, Stanislaw Czekalski, Thierry Hannedouche, Stefan H. Jacobson, Alfredo Loureiro, Alejandro Martin-Malo, Menelaos Papadimitriou, Jutta Passlick-Deetjen, Claudio Ronco, Raymond Vanholder, Volker Wizemann, The MPO Study: Just a European HEMO Study or Something Very Different? Blood Purification. ,vol. 26, pp. 100- 104 ,(2008) , 10.1159/000110574
Garabed Eknoyan, Gerald J. Beck, Alfred K. Cheung, John T. Daugirdas, Tom Greene, John W. Kusek, Michael Allon, James Bailey, James A. Delmez, Thomas A. Depner, Johanna T. Dwyer, Andrew S. Levey, Nathan W. Levin, Edgar Milford, Daniel B. Ornt, Michael V. Rocco, Gerald Schulman, Steve J. Schwab, Brendan P. Teehan, Robert Toto, Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis The New England Journal of Medicine. ,vol. 347, pp. 2010- 2019 ,(2002) , 10.1056/NEJMOA021583
Susanne Schwalbe, Markus Holzhauer, Jürgen Schaeffer, Michael Galanski, Karl-Martin Koch, Jürgen Floege, β2-microglobulin associated amyloidosis: A vanishing complication of long-term hemodialysis? Kidney International. ,vol. 52, pp. 1077- 1083 ,(1997) , 10.1038/KI.1997.431